Springer Nature is making SARS-CoV-2 and COVID-19 research free.
View research |
View latest news |
Sign up for updates
From: Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial